Skip to main content
Day.News — Local News. Real Community.
HOHENWALD DAY NEWS
Local News. Real Community.

Health & Wellness

09/21/2026 · Hohenwald

Full Edition

FDA Approves New Pancreatic Cancer Drug Rasonque

The U.S. Food and Drug Administration approved Rasonque, a RAS inhibitor, for advanced pancreatic cancer. This decision provides a new treatment option for patients earlier than anticipated.

09/13/2026
Read Story
Health

FDA Authorizes First Device to Continuously Monitor Glucose and Ketones

The U.S. Food and Drug Administration has authorized the first wearable device that continuously monitors both ketone levels and blood sugar. The Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System received approval for use by individuals aged two years and older living with diabetes.

09/13/2026 · Tennessee

Health

Peer-Reviewed Study Reports on New Blood Test for Early Breast Cancer Detection

A new peer-reviewed study details a blood test for early-stage breast cancer, reporting over 92% sensitivity and specificity. Researchers indicate the test's performance surpasses current supplemental screening methods. The study comes from a team at Astrin Biosciences.

08/23/2026 · Tennessee

Health

FDA Approves Subcutaneous Lecanemab for Early Alzheimer's Treatment

The Food and Drug Administration has approved LEQEMBI IQLIK (lecanemab-irmb), a subcutaneous injection for early Alzheimer's disease. This formulation allows for at-home dosing, broadening administration options for patients.

08/21/2026 · Tennessee

Health

Survey Identifies Generational Differences in Healthcare System Perceptions

A recent national survey reveals differences in how age groups perceive the U.S. healthcare system. Gen Z and Millennial voters more frequently identified systemic failures, especially regarding women's health services.

08/21/2026 · Tennessee

Health

FDA Approves Subcutaneous Leqembi Starting Dose for Alzheimer's Treatment

The FDA has approved a weekly subcutaneous starting dose for Leqembi, a drug for early Alzheimer's. This approval provides an alternative administration method for patients. The Alzheimer's Drug Discovery Foundation commented on the development.

08/19/2026 · Tennessee

More Health & Wellness

Sponsored

Advertisement

Advertisement

Advertisement